Stuart Henderson

BioCity Group Ltd (BioCity) is a venture capital firm founded in 2002. The firm is headquartered in London, United Kingdom.

Part of Deloitte LLP (New York), Deloitte LLP (United Kingdom) provides brokerage services. The company is based in London, UK. David Sproul has been the CEO of the British company since 2003.

Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom.

Norwich Research Partners LLP operates as a business community. The private company is based in Norwich, UK. The British company was founded in 2012. The CEO is David Parfrey.

One Nucleus Ltd. is a life science membership organization that supports the largest life science cluster in the East of England region through knowledge transfer, connectivity, inward investment, and growth. The non-profit company is based in Cambridge, UK. Sphere Fluidics, a British company commercializing single cell analysis systems, introduced the Cyto-Cellect™ Human IgGK Detection Kit, to be used in conjunction with the Cyto-Mine® Single Cell Analysis System for rapid and cost-effective measurement of antibody class and productivity in cell. Marks & Clerk, a global intellectual property firm, announced that Associates Graham McGlashan and Erik Rõuk will be attending the 7th International XR Conference, taking place in partnership with The Manchester Metropolitan University, ISCTE - Instituto Universitario de Lisboa and the International Association of Immersive Technology Innovation. BioIVT, a leading provider of research models and services for drug and diagnostic development, recently acquired Keystone Biologicals, Inc., a supplier of disease-state plasma, sera, and controls.

Babraham Institute operates as charitable life sciences organization. It is a registered charity, sponsored by the Biotechnology and Biological Sciences Research Council. Babraham Institute is headquartered in Cambridge, GB.